Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $2.53 Analyst target: $5.72 Upside: 126.09%
Tilray Inc. is dedicated to the research, cultivation, production and distribution of medicinal cannabis and cannabinoids. The company is headquartered in Leamington, Canada.
See the full interactive analysis & chart →Informational only — not investment advice.